Data highlights effectiveness of EVER001 in treating pMN
Category: News
Immunocore has announced that Kimmtrak (tebentafusp) has been recommended for funding in England by the National Institute for […]
Partnership aims to develop new radiopharmaceuticals for cancer treatment
New SureSeq CLL + CNV V3 panel improves understanding of CLL
Race to create first oral drug for obesity intensifies
Injection significantly reduces need for further treatment
Therapy for autoimmune disorder shows potential
The biotech will use the funding to drive sales of its first commercial product
The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles
The census found that 56% of people visit their GP for a UTI and 27% for thrush